According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

The FDA issued two policies April 12 to establish approaches for the design and validation of next-generation sequencing tests. Next-generation sequencing tests review a person’s DNA to diagnose ...

Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Metagenomic next‐generation sequencing (mNGS) is revolutionising infectious disease diagnosis by enabling an unbiased interrogation of all genetic material within a clinical sample. This approach ...

This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

As questions surrounding paternity fraud and DNA disputes gain prominence, experts maintain that despite the introduction of Next Generation Sequencing [NGS] Capillary Electrophoresis [CE] precision, ...

In a recent study, scientists sounded the alarm on the vulnerability of DNA data, particularly those obtained through next-generation DNA sequencing (NGS), against nefarious hackers. While no known ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...